FDA-Cleared Home LLLT Devices for Pattern Hair Loss: Lueangarun 2021 Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Journal of Clinical and Aesthetic Dermatology, 2021
FDA-Cleared Home LLLT Devices for Pattern Hair Loss: Lueangarun 2021 Research Summary
Study conclusion
FDA-cleared home laser devices significantly increased hair density compared to fake devices across 7 controlled trials involving 607 participants, according to this 2021 meta-analysis. The result held for both men and women, and for both comb-type and helmet-type devices. However, studies varied considerably in how results were measured, which reduces confidence in the precise size of the effect.
Strength of evidence
Who it applies to
Who was studied
Men and women with pattern hair loss across a range of severity levels. Male participants had Norwood-Hamilton grades IIa to VII; female participants had Ludwig-Savin grades I to II. Mean ages ranged from approximately 37 to 52 years across trials. Total: 607 participants across 7 trials.
Who was NOT studied
People with severe pattern hair loss (Norwood grade VI or VII) were underrepresented, as most trials enrolled mild to moderate cases. People with other types of hair loss (alopecia areata, scarring alopecias) were excluded. No trial measured real-world home use patterns.
What to look for when shopping
All devices in the trials used wavelengths in the red light range (630-678nm) at low power (5mW or less per diode). Both comb-type and helmet-type devices produced significant results. Treatment sessions ranged from 8 to 30 minutes, 3 times per week to daily, over 16 to 26 weeks.
What research cannot help you decide
The trials do not identify which specific device to buy. Most of the 32 FDA-cleared devices on the market at the time had no published clinical trial data of their own. The studies cannot tell you how long results last after stopping treatment, or how LLLT compares head-to-head against minoxidil or finasteride.
Key findings
- FDA-cleared home laser devices significantly increased hair density compared to sham devices across 7 controlled trials (607 participants).
- The effect was significant in both men and women, with no meaningful difference between sexes.
- Both comb-type and helmet-type devices produced significant hair density improvements.
- Devices using laser diodes alone showed a stronger effect than those combining laser diodes with LEDs, though both were significant.
- Side effects were mild and infrequent: scalp dryness, itching, and mild skin irritation in a small number of users.
- As of January 2020, only 32 of the 58 LLLT devices in the FDA database were commercially marketed in the US, and most had no published clinical trial data.
What they found
| Comparison | Result | Significant? |
|---|---|---|
| FDA-cleared LLLT devices vs sham: all 7 trials, 607 participants | Significant increase in hair density favouring LLLT (large effect, but high variation between studies) | Yes |
| LLLT vs sham: men only | Significant increase in hair density in men (moderate-to-high variation between male studies) | Yes |
| LLLT vs sham: women only | Significant increase in hair density in women (very low variation between female studies) | Yes |
| Comb-type devices vs sham | Significant increase in hair density with comb-type devices | Yes |
| Helmet-type devices vs sham | Significant increase in hair density with helmet-type devices | Yes |
| Laser diodes alone vs sham | Significant increase, stronger effect than combination devices | Yes |
| Laser diodes + LEDs combination vs sham | Significant increase, but smaller effect than laser-diode-only devices | Yes |
What this study does not show
- 1.Whether results last after stopping. The longest trial ran 26 weeks. No trial tracked what happened after treatment ended.
- 2.Whether any specific brand performs better. No trial compared one FDA-cleared device directly against another.
- 3.Whether diode count affects results. None of the 7 trials compared devices by diode count.
- 4.Whether devices with near-infrared wavelengths work better. No trial in this review tested near-infrared for pattern hair loss.
- 5.Whether results apply to darker skin tones. Fitzpatrick skin types V and VI were excluded from all included trials.
Limitations
- 1.Only 7 of 32 FDA-cleared home devices had published randomised controlled trial data as of January 2020.
- 2.Maximum follow-up was 26 weeks. Long-term effects are unknown.
- 3.Most trials did not report irradiance values. Optimal dosing cannot be determined from this review.
- 4.High variability across trials — different devices, protocols, and outcome measures.
- 5.Individual trial sample sizes were small.
- 6.Most trials were conducted in Asian populations. Generalisability to other ethnic populations is uncertain.
Used in these articles
Links added as fact-checks and articles citing this study are published.